Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
498
-
Total 13F shares, excl. options
-
59M
-
Shares change
-
+1.12M
-
Total reported value, excl. options
-
$7.26B
-
Value change
-
+$147M
-
Put/Call ratio
-
0.47
-
Number of buys
-
234
-
Number of sells
-
-223
-
Price
-
$123.15
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2024
565 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q4 2024.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 498 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (6.04M shares), BlackRock, Inc. (5.85M shares), LSV ASSET MANAGEMENT (2.53M shares), Pacer Advisors, Inc. (2.21M shares), DIMENSIONAL FUND ADVISORS LP (2.04M shares), STATE STREET CORP (1.97M shares), Capital World Investors (1.92M shares), AMERIPRISE FINANCIAL INC (1.83M shares), EcoR1 Capital, LLC (1.71M shares), and JPMORGAN CHASE & CO (1.59M shares).
This table shows the top 498 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.